Merdury Biopharmaceutical Corp
TPEX:6932
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
M
|
Merdury Biopharmaceutical Corp
TPEX:6932
|
TW |
|
J
|
JCK International PCL
SET:JCK
|
TH |
|
Temas Resources Corp
OTC:TMASF
|
CA |
|
I
|
Infrastrutture Wireless Italiane SpA
F:WI8
|
IT |
|
Nuinsco Resources Ltd
F:NJX
|
CA |
|
M
|
McFarlane Lake Mining Ltd
NEO:MLM
|
CA |
|
McPherson's Ltd
F:M5C
|
AU |
|
L
|
LaserOptek Co Ltd
KOSDAQ:199550
|
KR |
|
Etteplan Oyj
F:EPL
|
FI |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Merdury Biopharmaceutical Corp.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Merdury Biopharmaceutical
Merdury Biopharmaceutical Corp. manufactures pharmaceutical products. The company is headquartered in Taipei, New Taipei. The company went IPO on 2022-12-23. The firm mainly focuses on the development of drugs that do not meet special medical needs, difficult generic drugs and second-class new drugs. With the self-developed and multi-national patented drug development platform StackDose, the Company can develop products that can achieve controllable time-dissolving (instant or sustained release) tablets, thereby controlling the time for the drug to take effect.
- Sede central
- Taiwán TW
- Empleados
- 13
- Fecha de salida a bolsa
- 23 dic., 2022
